 | • レポートコード：QYR2104Z0033 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、96ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥546,000 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥819,000 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,092,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、先端巨大症のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（ソマトスタチン類似体、ドーパミン作動薬、成長ホルモン受容体拮抗薬、その他）、用途別市場規模（病院、クリニック）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・先端巨大症の市場動向 ・企業の競争状況、市場シェア ・先端巨大症の種類別市場規模（ソマトスタチン類似体、ドーパミン作動薬、成長ホルモン受容体拮抗薬、その他） ・先端巨大症の用途別市場規模（病院、クリニック） ・先端巨大症の北米市場規模2016-2027（アメリカ、カナダ） ・先端巨大症のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・先端巨大症のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・先端巨大症の中南米市場規模2016-2027（メキシコ、ブラジル） ・先端巨大症の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Novartis、Aegis Therapeutics、Chiasma、Crinetics Pharmaceuticals、Daewoong Pharmaceutical、Peptron、Silence Therapeutics、Strongbridge Biopharma、Amryt Pharma、Foresee Pharmaceuticals、Glide Pharmaceutical、Ionis Pharmaceuticals、Ipsen） ・結論 |
Acromegaly is a hormonal disorder that develops when your pituitary gland produces too much growth hormone during adulthood. When this happens, your bones increase in size, including those of your hands, feet and face. Acromegalyusually affects middle-aged adults.
Market Analysis and Insights: Global Acromegaly Market
The global Acromegaly market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Acromegaly market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Acromegaly market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Acromegaly market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Acromegaly market.
Global Acromegaly Scope and Market Size
Acromegaly market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Acromegaly market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Somatostatin Analogues
Dopamine Agonists
Growth Hormone Receptor Antagonists
Other
Segment by Application
Hospitals
Clinics
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Novartis
Aegis Therapeutics
Chiasma
Crinetics Pharmaceuticals
Daewoong Pharmaceutical
Peptron
Silence Therapeutics
Strongbridge Biopharma
Amryt Pharma
Crinetics Pharmaceuticals
Daewoong Pharmaceutical
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Acromegaly Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Somatostatin Analogues
1.2.3 Dopamine Agonists
1.2.4 Growth Hormone Receptor Antagonists
1.2.5 Other
1.3 Market by Application
1.3.1 Global Acromegaly Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinics
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Acromegaly Market Perspective (2016-2027)
2.2 Acromegaly Growth Trends by Regions
2.2.1 Acromegaly Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Acromegaly Historic Market Share by Regions (2016-2021)
2.2.3 Acromegaly Forecasted Market Size by Regions (2022-2027)
2.3 Acromegaly Industry Dynamic
2.3.1 Acromegaly Market Trends
2.3.2 Acromegaly Market Drivers
2.3.3 Acromegaly Market Challenges
2.3.4 Acromegaly Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Acromegaly Players by Revenue
3.1.1 Global Top Acromegaly Players by Revenue (2016-2021)
3.1.2 Global Acromegaly Revenue Market Share by Players (2016-2021)
3.2 Global Acromegaly Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Acromegaly Revenue
3.4 Global Acromegaly Market Concentration Ratio
3.4.1 Global Acromegaly Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Acromegaly Revenue in 2020
3.5 Acromegaly Key Players Head office and Area Served
3.6 Key Players Acromegaly Product Solution and Service
3.7 Date of Enter into Acromegaly Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Acromegaly Breakdown Data by Type
4.1 Global Acromegaly Historic Market Size by Type (2016-2021)
4.2 Global Acromegaly Forecasted Market Size by Type (2022-2027)
5 Acromegaly Breakdown Data by Application
5.1 Global Acromegaly Historic Market Size by Application (2016-2021)
5.2 Global Acromegaly Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Acromegaly Market Size (2016-2027)
6.2 North America Acromegaly Market Size by Type
6.2.1 North America Acromegaly Market Size by Type (2016-2021)
6.2.2 North America Acromegaly Market Size by Type (2022-2027)
6.2.3 North America Acromegaly Market Size by Type (2016-2027)
6.3 North America Acromegaly Market Size by Application
6.3.1 North America Acromegaly Market Size by Application (2016-2021)
6.3.2 North America Acromegaly Market Size by Application (2022-2027)
6.3.3 North America Acromegaly Market Size by Application (2016-2027)
6.4 North America Acromegaly Market Size by Country
6.4.1 North America Acromegaly Market Size by Country (2016-2021)
6.4.2 North America Acromegaly Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Acromegaly Market Size (2016-2027)
7.2 Europe Acromegaly Market Size by Type
7.2.1 Europe Acromegaly Market Size by Type (2016-2021)
7.2.2 Europe Acromegaly Market Size by Type (2022-2027)
7.2.3 Europe Acromegaly Market Size by Type (2016-2027)
7.3 Europe Acromegaly Market Size by Application
7.3.1 Europe Acromegaly Market Size by Application (2016-2021)
7.3.2 Europe Acromegaly Market Size by Application (2022-2027)
7.3.3 Europe Acromegaly Market Size by Application (2016-2027)
7.4 Europe Acromegaly Market Size by Country
7.4.1 Europe Acromegaly Market Size by Country (2016-2021)
7.4.2 Europe Acromegaly Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Acromegaly Market Size (2016-2027)
8.2 Asia-Pacific Acromegaly Market Size by Type
8.2.1 Asia-Pacific Acromegaly Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Acromegaly Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Acromegaly Market Size by Type (2016-2027)
8.3 Asia-Pacific Acromegaly Market Size by Application
8.3.1 Asia-Pacific Acromegaly Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Acromegaly Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Acromegaly Market Size by Application (2016-2027)
8.4 Asia-Pacific Acromegaly Market Size by Region
8.4.1 Asia-Pacific Acromegaly Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Acromegaly Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Acromegaly Market Size (2016-2027)
9.2 Latin America Acromegaly Market Size by Type
9.2.1 Latin America Acromegaly Market Size by Type (2016-2021)
9.2.2 Latin America Acromegaly Market Size by Type (2022-2027)
9.2.3 Latin America Acromegaly Market Size by Type (2016-2027)
9.3 Latin America Acromegaly Market Size by Application
9.3.1 Latin America Acromegaly Market Size by Application (2016-2021)
9.3.2 Latin America Acromegaly Market Size by Application (2022-2027)
9.3.3 Latin America Acromegaly Market Size by Application (2016-2027)
9.4 Latin America Acromegaly Market Size by Country
9.4.1 Latin America Acromegaly Market Size by Country (2016-2021)
9.4.2 Latin America Acromegaly Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Acromegaly Market Size (2016-2027)
10.2 Middle East & Africa Acromegaly Market Size by Type
10.2.1 Middle East & Africa Acromegaly Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Acromegaly Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Acromegaly Market Size by Type (2016-2027)
10.3 Middle East & Africa Acromegaly Market Size by Application
10.3.1 Middle East & Africa Acromegaly Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Acromegaly Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Acromegaly Market Size by Application (2016-2027)
10.4 Middle East & Africa Acromegaly Market Size by Country
10.4.1 Middle East & Africa Acromegaly Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Acromegaly Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Novartis
11.1.1 Novartis Company Details
11.1.2 Novartis Business Overview
11.1.3 Novartis Acromegaly Introduction
11.1.4 Novartis Revenue in Acromegaly Business (2016-2021)
11.1.5 Novartis Recent Development
11.2 Aegis Therapeutics
11.2.1 Aegis Therapeutics Company Details
11.2.2 Aegis Therapeutics Business Overview
11.2.3 Aegis Therapeutics Acromegaly Introduction
11.2.4 Aegis Therapeutics Revenue in Acromegaly Business (2016-2021)
11.2.5 Aegis Therapeutics Recent Development
11.3 Chiasma
11.3.1 Chiasma Company Details
11.3.2 Chiasma Business Overview
11.3.3 Chiasma Acromegaly Introduction
11.3.4 Chiasma Revenue in Acromegaly Business (2016-2021)
11.3.5 Chiasma Recent Development
11.4 Crinetics Pharmaceuticals
11.4.1 Crinetics Pharmaceuticals Company Details
11.4.2 Crinetics Pharmaceuticals Business Overview
11.4.3 Crinetics Pharmaceuticals Acromegaly Introduction
11.4.4 Crinetics Pharmaceuticals Revenue in Acromegaly Business (2016-2021)
11.4.5 Crinetics Pharmaceuticals Recent Development
11.5 Daewoong Pharmaceutical
11.5.1 Daewoong Pharmaceutical Company Details
11.5.2 Daewoong Pharmaceutical Business Overview
11.5.3 Daewoong Pharmaceutical Acromegaly Introduction
11.5.4 Daewoong Pharmaceutical Revenue in Acromegaly Business (2016-2021)
11.5.5 Daewoong Pharmaceutical Recent Development
11.6 Peptron
11.6.1 Peptron Company Details
11.6.2 Peptron Business Overview
11.6.3 Peptron Acromegaly Introduction
11.6.4 Peptron Revenue in Acromegaly Business (2016-2021)
11.6.5 Peptron Recent Development
11.7 Silence Therapeutics
11.7.1 Silence Therapeutics Company Details
11.7.2 Silence Therapeutics Business Overview
11.7.3 Silence Therapeutics Acromegaly Introduction
11.7.4 Silence Therapeutics Revenue in Acromegaly Business (2016-2021)
11.7.5 Silence Therapeutics Recent Development
11.8 Strongbridge Biopharma
11.8.1 Strongbridge Biopharma Company Details
11.8.2 Strongbridge Biopharma Business Overview
11.8.3 Strongbridge Biopharma Acromegaly Introduction
11.8.4 Strongbridge Biopharma Revenue in Acromegaly Business (2016-2021)
11.8.5 Strongbridge Biopharma Recent Development
11.9 Amryt Pharma
11.9.1 Amryt Pharma Company Details
11.9.2 Amryt Pharma Business Overview
11.9.3 Amryt Pharma Acromegaly Introduction
11.9.4 Amryt Pharma Revenue in Acromegaly Business (2016-2021)
11.9.5 Amryt Pharma Recent Development
11.10 Foresee Pharmaceuticals
11.10.1 Foresee Pharmaceuticals Company Details
11.10.2 Foresee Pharmaceuticals Business Overview
11.10.3 Foresee Pharmaceuticals Acromegaly Introduction
11.10.4 Foresee Pharmaceuticals Revenue in Acromegaly Business (2016-2021)
11.10.5 Foresee Pharmaceuticals Recent Development
11.11 Glide Pharmaceutical
11.11.1 Glide Pharmaceutical Company Details
11.11.2 Glide Pharmaceutical Business Overview
11.11.3 Glide Pharmaceutical Acromegaly Introduction
11.11.4 Glide Pharmaceutical Revenue in Acromegaly Business (2016-2021)
11.11.5 Glide Pharmaceutical Recent Development
11.12 Ionis Pharmaceuticals
11.12.1 Ionis Pharmaceuticals Company Details
11.12.2 Ionis Pharmaceuticals Business Overview
11.12.3 Ionis Pharmaceuticals Acromegaly Introduction
11.12.4 Ionis Pharmaceuticals Revenue in Acromegaly Business (2016-2021)
11.12.5 Ionis Pharmaceuticals Recent Development
11.13 Ipsen
11.13.1 Ipsen Company Details
11.13.2 Ipsen Business Overview
11.13.3 Ipsen Acromegaly Introduction
11.13.4 Ipsen Revenue in Acromegaly Business (2016-2021)
11.13.5 Ipsen Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Acromegaly Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Somatostatin Analogues
Table 3. Key Players of Dopamine Agonists
Table 4. Key Players of Growth Hormone Receptor Antagonists
Table 5. Key Players of Other
Table 6. Global Acromegaly Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Acromegaly Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Acromegaly Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Acromegaly Market Share by Regions (2016-2021)
Table 10. Global Acromegaly Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Acromegaly Market Share by Regions (2022-2027)
Table 12. Acromegaly Market Trends
Table 13. Acromegaly Market Drivers
Table 14. Acromegaly Market Challenges
Table 15. Acromegaly Market Restraints
Table 16. Global Acromegaly Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Acromegaly Market Share by Players (2016-2021)
Table 18. Global Top Acromegaly Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Acromegaly as of 2020)
Table 19. Ranking of Global Top Acromegaly Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Acromegaly Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Acromegaly Product Solution and Service
Table 23. Date of Enter into Acromegaly Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Acromegaly Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Acromegaly Revenue Market Share by Type (2016-2021)
Table 27. Global Acromegaly Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Acromegaly Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Acromegaly Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Acromegaly Revenue Market Share by Application (2016-2021)
Table 31. Global Acromegaly Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Acromegaly Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Acromegaly Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Acromegaly Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Acromegaly Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Acromegaly Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Acromegaly Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Acromegaly Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Acromegaly Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Acromegaly Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Acromegaly Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Acromegaly Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Acromegaly Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Acromegaly Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Acromegaly Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Acromegaly Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Acromegaly Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Acromegaly Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Acromegaly Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Acromegaly Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Acromegaly Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Acromegaly Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Acromegaly Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Acromegaly Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Acromegaly Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Acromegaly Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Acromegaly Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Acromegaly Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Acromegaly Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Acromegaly Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Acromegaly Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Acromegaly Market Size by Country (2022-2027) & (US$ Million)
Table 63. Novartis Company Details
Table 64. Novartis Business Overview
Table 65. Novartis Acromegaly Product
Table 66. Novartis Revenue in Acromegaly Business (2016-2021) & (US$ Million)
Table 67. Novartis Recent Development
Table 68. Aegis Therapeutics Company Details
Table 69. Aegis Therapeutics Business Overview
Table 70. Aegis Therapeutics Acromegaly Product
Table 71. Aegis Therapeutics Revenue in Acromegaly Business (2016-2021) & (US$ Million)
Table 72. Aegis Therapeutics Recent Development
Table 73. Chiasma Company Details
Table 74. Chiasma Business Overview
Table 75. Chiasma Acromegaly Product
Table 76. Chiasma Revenue in Acromegaly Business (2016-2021) & (US$ Million)
Table 77. Chiasma Recent Development
Table 78. Crinetics Pharmaceuticals Company Details
Table 79. Crinetics Pharmaceuticals Business Overview
Table 80. Crinetics Pharmaceuticals Acromegaly Product
Table 81. Crinetics Pharmaceuticals Revenue in Acromegaly Business (2016-2021) & (US$ Million)
Table 82. Crinetics Pharmaceuticals Recent Development
Table 83. Daewoong Pharmaceutical Company Details
Table 84. Daewoong Pharmaceutical Business Overview
Table 85. Daewoong Pharmaceutical Acromegaly Product
Table 86. Daewoong Pharmaceutical Revenue in Acromegaly Business (2016-2021) & (US$ Million)
Table 87. Daewoong Pharmaceutical Recent Development
Table 88. Peptron Company Details
Table 89. Peptron Business Overview
Table 90. Peptron Acromegaly Product
Table 91. Peptron Revenue in Acromegaly Business (2016-2021) & (US$ Million)
Table 92. Peptron Recent Development
Table 93. Silence Therapeutics Company Details
Table 94. Silence Therapeutics Business Overview
Table 95. Silence Therapeutics Acromegaly Product
Table 96. Silence Therapeutics Revenue in Acromegaly Business (2016-2021) & (US$ Million)
Table 97. Silence Therapeutics Recent Development
Table 98. Strongbridge Biopharma Company Details
Table 99. Strongbridge Biopharma Business Overview
Table 100. Strongbridge Biopharma Revenue in Acromegaly Business (2016-2021) & (US$ Million)
Table 101. Strongbridge Biopharma Recent Development
Table 102. Amryt Pharma Company Details
Table 103. Amryt Pharma Business Overview
Table 104. Amryt Pharma Acromegaly Product
Table 105. Amryt Pharma Revenue in Acromegaly Business (2016-2021) & (US$ Million)
Table 106. Amryt Pharma Recent Development
Table 107. Foresee Pharmaceuticals Company Details
Table 108. Foresee Pharmaceuticals Business Overview
Table 109. Foresee Pharmaceuticals Acromegaly Product
Table 110. Foresee Pharmaceuticals Revenue in Acromegaly Business (2016-2021) & (US$ Million)
Table 111. Foresee Pharmaceuticals Recent Development
Table 112. Glide Pharmaceutical Company Details
Table 113. Glide Pharmaceutical Business Overview
Table 114. Glide Pharmaceutical Acromegaly Product
Table 115. Glide Pharmaceutical Revenue in Acromegaly Business (2016-2021) & (US$ Million)
Table 116. Glide Pharmaceutical Recent Development
Table 117. Ionis Pharmaceuticals Company Details
Table 118. Ionis Pharmaceuticals Business Overview
Table 119. Ionis Pharmaceuticals Acromegaly Product
Table 120. Ionis Pharmaceuticals Revenue in Acromegaly Business (2016-2021) & (US$ Million)
Table 121. Ionis Pharmaceuticals Recent Development
Table 122. Ipsen Company Details
Table 123. Ipsen Business Overview
Table 124. Ipsen Acromegaly Product
Table 125. Ipsen Revenue in Acromegaly Business (2016-2021) & (US$ Million)
Table 126. Ipsen Recent Development
Table 127. Research Programs/Design for This Report
Table 128. Key Data Information from Secondary Sources
Table 129. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Acromegaly Market Share by Type: 2020 VS 2027
Figure 2. Somatostatin Analogues Features
Figure 3. Dopamine Agonists Features
Figure 4. Growth Hormone Receptor Antagonists Features
Figure 5. Other Features
Figure 6. Global Acromegaly Market Share by Application: 2020 VS 2027
Figure 7. Hospitals Case Studies
Figure 8. Clinics Case Studies
Figure 9. Acromegaly Report Years Considered
Figure 10. Global Acromegaly Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Acromegaly Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Acromegaly Market Share by Regions: 2020 VS 2027
Figure 13. Global Acromegaly Market Share by Regions (2022-2027)
Figure 14. Global Acromegaly Market Share by Players in 2020
Figure 15. Global Top Acromegaly Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Acromegaly as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Acromegaly Revenue in 2020
Figure 17. Global Acromegaly Revenue Market Share by Type (2016-2021)
Figure 18. Global Acromegaly Revenue Market Share by Type (2022-2027)
Figure 19. North America Acromegaly Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Acromegaly Market Share by Type (2016-2027)
Figure 21. North America Acromegaly Market Share by Application (2016-2027)
Figure 22. North America Acromegaly Market Share by Country (2016-2027)
Figure 23. United States Acromegaly Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Acromegaly Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Acromegaly Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Acromegaly Market Share by Type (2016-2027)
Figure 27. Europe Acromegaly Market Share by Application (2016-2027)
Figure 28. Europe Acromegaly Market Share by Country (2016-2027)
Figure 29. Germany Acromegaly Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Acromegaly Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Acromegaly Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Acromegaly Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Acromegaly Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Acromegaly Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Acromegaly Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Acromegaly Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Acromegaly Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Acromegaly Market Share by Region (2016-2027)
Figure 39. China Acromegaly Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Acromegaly Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Acromegaly Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Acromegaly Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Acromegaly Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Acromegaly Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Acromegaly Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Acromegaly Market Share by Type (2016-2027)
Figure 47. Latin America Acromegaly Market Share by Application (2016-2027)
Figure 48. Latin America Acromegaly Market Share by Country (2016-2027)
Figure 49. Mexico Acromegaly Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Acromegaly Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Acromegaly Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Acromegaly Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Acromegaly Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Acromegaly Market Share by Country (2016-2027)
Figure 55. Turkey Acromegaly Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Acromegaly Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Acromegaly Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Novartis Revenue Growth Rate in Acromegaly Business (2016-2021)
Figure 59. Aegis Therapeutics Revenue Growth Rate in Acromegaly Business (2016-2021)
Figure 60. Chiasma Revenue Growth Rate in Acromegaly Business (2016-2021)
Figure 61. Crinetics Pharmaceuticals Revenue Growth Rate in Acromegaly Business (2016-2021)
Figure 62. Daewoong Pharmaceutical Revenue Growth Rate in Acromegaly Business (2016-2021)
Figure 63. Peptron Revenue Growth Rate in Acromegaly Business (2016-2021)
Figure 64. Silence Therapeutics Revenue Growth Rate in Acromegaly Business (2016-2021)
Figure 65. Strongbridge Biopharma Revenue Growth Rate in Acromegaly Business (2016-2021)
Figure 66. Amryt Pharma Revenue Growth Rate in Acromegaly Business (2016-2021)
Figure 67. Foresee Pharmaceuticals Revenue Growth Rate in Acromegaly Business (2016-2021)
Figure 68. Glide Pharmaceutical Revenue Growth Rate in Acromegaly Business (2016-2021)
Figure 69. Ionis Pharmaceuticals Revenue Growth Rate in Acromegaly Business (2016-2021)
Figure 70. Ipsen Revenue Growth Rate in Acromegaly Business (2016-2021)
Figure 71. Bottom-up and Top-down Approaches for This Report
Figure 72. Data Triangulation
Figure 73. Key Executives Interviewed
世界の先端巨大症市場 2021：企業別、地域別、種類・用途別 The Acromegaly market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent …- 世界の先端巨大症治療市場規模・現状・予測（2021年-2027年） Acromegaly is a disorder that results from excess growth hormone (GH) after the growth plates have closed. In this report, we study the drugs for Acromegaly. Market Analysis and Insights: Global Acromegaly Therapeutics Market The global Acromegaly Therapeutics market size is projected to reach US$ X…
- 世界のクッシング症候群・先端巨大症治療市場規模・現状・予測（2021年-2027年） Cushing's syndrome involves symptoms such as high blood pressure, abdominal obesity, round red face, a fatty lump between the shoulders, weak muscles and bones, acne, fragile skin and others. Most Cushing's syndrome cases are caused by pituitary adenoma, and multiple endocrine neoplasia. Acromegaly …
- 世界の先端巨大症治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Acromegaly Treatment Market The global Acromegaly Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity, the report m…
- 世界の先端巨大症治療市場 2021：企業別、地域別、種類・用途別 The Acromegaly Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulation…